Cargando…
Development of a risk scoring system for patients with papillary thyroid cancer
As the importance of personalized therapeutics in aggressive papillary thyroid cancer (PTC) increases, accurate risk stratification is required. To develop a novel prognostic scoring system for patients with PTC (n = 455), we used mRNA expression and clinical data from The Cancer Genome Atlas. We pe...
Autores principales: | Pak, Kyoungjune, Kim, Yun Hak, Suh, Sunghwan, Goh, Tae Sik, Jeong, Dae Cheon, Kim, Seong Jang, Kim, In Joo, Han, Myoung‐Eun, Oh, Sae‐Ock |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433682/ https://www.ncbi.nlm.nih.gov/pubmed/30729678 http://dx.doi.org/10.1111/jcmm.14208 |
Ejemplares similares
-
Development and Validation of a Risk Scoring System Derived from Meta-Analyses of Papillary Thyroid Cancer
por: Suh, Sunghwan, et al.
Publicado: (2020) -
Corrigendum: Affiliation Correction. Development and Validation of a Risk Scoring System Derived from Meta-Analyses for Papillary Thyroid Cancer
por: Suh, Sunghwan, et al.
Publicado: (2023) -
mRNA Expression of SLC5A5 and SLC2A Family Genes in Papillary Thyroid Cancer: An Analysis of The Cancer Genome Atlas
por: Suh, Sunghwan, et al.
Publicado: (2018) -
Prognostic Value of MicroRNAs in Coronary Artery Diseases: A Meta-Analysis
por: Kim, Ji Suk, et al.
Publicado: (2018) -
Multi-omics analysis revealed TEK and AXIN2 are potential biomarkers in multifocal papillary thyroid cancer
por: Kim, Ga Hyun, et al.
Publicado: (2022)